薬品有効成分の世界市場:合成種類別(バイオテック、合成)、メーカー種類別(キャプティブ、マーチャント)、種類別、用途別、地域別

◆英語タイトル:Active Pharmaceutical Ingredient Market Size, Share & Trends Analysis Report By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY030
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年2月20日
◆ページ数:143
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、薬品有効成分の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、市場動向、競争分析、合成種類別(バイオテック、合成)分析、メーカー種類別(キャプティブ、マーチャント)分析、種類別分析、用途別(循環器学、腫瘍学、中枢神経学、整形外科、その他)分析、地域別分析、競争状況などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・市場動向
・競争分析
・薬品有効成分の世界市場:合成種類別(バイオテック、合成)
・薬品有効成分の世界市場:メーカー種類別(キャプティブ、マーチャント)
・薬品有効成分の世界市場:種類別
・薬品有効成分の世界市場:用途別(循環器学、腫瘍学、中枢神経学、整形外科、その他)
・薬品有効成分の世界市場:地域別
・競争状況
【レポートの概要】

The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth.

A steady rise in consumer demand for APIs, especially in developing and under-developed countries, increases the adoption of these products. In addition, strategic collaborations play a key role in the adoption of these ingredients in various regions. For instance, in February 2019, Cipla Inc. partnered with Wellthy Therapeutics Private Limited to combine digital therapeutics and pharmacotherapy for better patient outcomes in cardiovascular diseases and diabetes.

Private and public initiatives to manufacture active pharmaceutical ingredients within their countries, especially in developing countries such as India, is expected to drive the growth of the market. For instance, API production in India is promoted under the “Make in India” initiative.

Presence of prominent players and increasing government initiatives for the development of pharmaceuticals in various regions are also expected to boost the market growth. Increasing consumer awareness and demand for economical and effective treatment strategies, especially in Asia Pacific and Middle East and Africa, are driving the sales channels. In addition, high adoption and growing usage of online pharmacies are likely to drive the e-commerce sales of APIs.

The API market is competitive in nature and is becoming increasingly competitive. Consequently, manufacturers are required to enhance products in order to gain advantage over previously marketed products. For instance, in March 2019, Dr. Reddy’s Laboratories Ltd. launched XCEED-a B2B customer service portal. The platform was designed to manage the growing demand for generic active pharmaceutical ingredients by significantly increasing operational efficiency.

Further key findings from the study suggest:

• On the basis of type of synthesis, the synthetic segment dominated the active pharmaceutical ingredients market in 2019 owing to easy availability of raw materials and easier protocols in place for the synthesis of these molecules

• The biotech segment is estimated to register the highest CAGR owing to higher efficiency of these molecules and increasing demand for biopharmaceuticals

• Captive manufacturers held the largest share in 2019 due to easy availability of raw materials

• The merchant manufacturers segment is estimated to witness a lucrative CAGR over the forecast period

• The generic segment is estimated to register the highest CAGR over the forecast period. The segment is driven by factors such as lower cost and expiration of patents of branded drugs

• Asia Pacific is estimated to register a significant CAGR of 8.0% owing to the increasing number of pharmaceutical manufacturing plants in the region

• Some of the key players in the API market are Mylan N.V.; Teva Pharmaceutical Industries Ltd.; Boehringer Ingelheim International GmbH; AbbVie Inc.; Merck & Co., Inc.; Cipla Inc.; Albemarle Corporation; Dr. Reddy’s Laboratories Ltd.; Bristol-Myers Squibb Company; Aurobindo Pharma; and Sun Pharmaceutical Industries Ltd.

【レポートの目次】

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Data Visualization
1.6 Validation & Publishing
1.7 Geographic Scope & Assumptions
1.8 Region-Wise Market Calculation
1.8.1 Region-Wise Market: Base Estimates
1.9 Market Cagr Calculation
1.9.1 Region Based Segment Share Calculation
Chapter 2 Executive Summary
2.1 API Market Outlook
2.2 API Market: – Segment Outlook
2.3 API Market: -Competitive Insights
2.4 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration And Growth Prospect Mapping
Chapter 4 Market Dynamics
4.1 Market Driver Analysis
4.1.1 Growing Geriatric Population Base
4.1.2 Growing Prevalence Of Target Diseases Such As Hospital Acquired Infections, Genetic, Cardiovascular And Neurological Diseases
4.1.3 Increasing Preference For Targeted Therapy Approach In Cancer Treatment
4.1.4 Increasing Preference For Outsourcing APIs
4.2 Market Restraint Analysis
4.2.1 Large Capital Investments And Production Cost
4.2.2 Stringent Safety And Handling Regulations Regarding APIs
Chapter 5 API Market Analysis Tools
5.1 Industry Analysis – Porter’s
5.1.1 Supplier Power: Moderate Due To Large Number Of Diagnostic Test Manufacturers
5.1.2 Buyer Power: Moderate Due To Presence Of Players Entering Into Long-Term Contract
5.1.3 Substitution Threat: Low Due To No/ Less External Substitutes
5.1.4 Threat From New Entrant: Moderate Due To Brand Recognition Of The Existing Players
5.1.5 Competitive Rivalry: High Due To Increasing Mergers & Acquisitions By Major Players
5.2 Pestel Analysis
5.2.1 Political Landscape
5.2.2 Environmental Landscape
5.2.3 Social Landscape
5.2.4 Technology Landscape
5.2.5 Legal Landscape
5.3 Major Deals & Strategic Alliances Analysis
5.3.1 Joint Ventures
5.3.2 Mergers & Acquisitions
5.3.3 Licensing & Partnership
5.3.4 Technology Collaborations
5.3.5 Strategic Divestments
Chapter 6 API Market – Competitive Analysis
6.1 Recent Developments & Impact Analysis, By Key Market Participants
6.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
6.3 Public Companies
6.3.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)
6.3.2 Company Market Share/Ranking, By Region
6.3.3 Competitive Dashboard Analysis
6.3.4 Market Differentiators
6.3.5 Synergy Analysis: Major Deals & Strategic Alliances
6.4 Private Companies
6.4.1 List Of Key Emerging Companies
6.4.2 Regional Network Map
6.4.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
Chapter 7 API Molecules Outlook
7.1 Global Sales (2015-2019)
7.2 Companies With Leading Market Position For API Molecules
7.2.1 Amoxicillin
7.2.2 Azithromycin
7.2.3 Bleomycin
7.2.4 Caspofungin
7.2.5 Clarithromycin
7.2.6 Clavulanic Acid
7.2.7 Clindamycin
7.2.8 Compactin (Mevastatin)
7.2.9 Cyclosporin
7.2.10 Dactinomycin
7.2.11 Daptomycin
7.2.12 Demeclocycline
7.2.13 Doxycycline
7.2.14 Erythromycin
7.2.15 Ivermectin (Avermectin)
7.2.16 Lovastatin
7.2.17 Micafungin
7.2.18 Minocycline
7.2.19 Mitomycin
7.2.20 Mycophenolic Acid
7.2.21 Pneumocandin B0
7.2.22 Polymyxin
7.2.23 Pravastatin
7.2.24 Rapamycin (Sirolimus)
7.2.25 Simvastatin
7.2.26 Steroids
7.2.27 Tacrolimus
7.2.28 Tetracycline
7.2.29 Tigecycline
7.2.30 Tobramycin
7.2.31 Vancomycin
7.3 Comparative Price Analysis Of The Above-Mentioned Molecules
Chapter 8 Type Of Synthesis Business Analysis
8.1. Definitions & Scope
8.2. Type of Synthesis Market Share Analysis, 2019 & 2027
8.3. API Market, by Type of Synthesis, 2015 to 2027
8.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
8.5 Biotech API
8.5.1 Biotech API Market, 2015 – 2027 (USD Billion)
8.5.2 Monoclonal Antibodies
8.5.2.1 Monoclonal Antibodies Market, 2015 – 2027 (USD Billion)
8.5.3 Recombinant Proteins
8.5.3.1 Recombinant Proteins Market, 2015 – 2027 (USD Billion)
8.5.4 Vaccines
8.5.4.1 Vaccines Market, 2015 – 2027 (USD Billion)
8.6 Synthetic API
8.6.1 Synthetic API Market, 2015 – 2027 (USD Billion)
Chapter 9 Type Of Manufacturer Business Analysis
9.1. Definitions & Scope
9.2. Type Of Manufacturer Market Share Analysis, 2019 & 2027
9.3. API Market, By Type Of Manufacturer, 2015 To 2027
9.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
9.5 Captive API
9.5.1 Captive API Market, 2015 – 2027 (USD Billion)
9.6 Merchant API
9.6.1 Merchant API Market, 2015 – 2027 (USD Billion)
Chapter 10 Type Business Analysis
10.1. Definitions & Scope
10.2. Type Market Share Analysis, 2019 & 2027
10.3. API Market, By Type, 2015 To 2027
10.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
10.5 Generic APIs
10.5.1 Generic API Market, 2015 – 2027 (USD Billion)
10.6 Innovative APIs
10.6.1 Innovative API Market, 2015 – 2027 (USD Billion)
Chapter 11 Application Business Analysis
11.1. Definitions & Scope
11.2. Application Market Share Analysis, 2019 & 2027
11.3. API Market, By Application, 2015 To 2027
11.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
11.5 Cardiology
11.5.1 Cardiology Market, 2015 – 2027 (USD Billion)
11.6 Oncology
11.6.1 Oncology Market, 2015 – 2027 (USD Billion)
11.7 Cns & Neurology
11.7.1 Cns & Neurology Market, 2015 – 2027 (USD Billion)
11.8 Orthopedics
11.8.1 Orthopedics Market, 2015 – 2027 (USD Billion)
11.9 Endocrinology
11.9.1 Endocrionology Market, 2015 – 2027 (USD Billion)
11.10 Pulmonology
11.10.1 Pulmonology Market, 2015 – 2027 (USD Billion)
11.11 Gastroenterology
11.11.1 Gastrointestinal Disorders Market, 2015 – 2027 (USD Billion)
11.12 Nephrology
11.12.1 Nephrology Market, 2015 – 2027 (USD Billion)
11.13 Ophthalmology
11.13.1 Opthalmology Market, 2015 – 2027 (USD Billion)
11.14 Others
11.14.1 Others Market, 2015 – 2027 (USD Billion)
Chapter 12 Application, By Type Business Analysis (Cross-Matrix)
12.1. Definitions & Scope
12.2. Application Market Share Analysis, 2019 & 2027
12.3. API Market, By Application, 2015 To 2027
12.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
12.5 Cardiology
12.5.1 Generic
12.5.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.5.2 Innovative
12.5.2.1 Innovative Market, 2015 – 2027 (USD Billion)
12.6 Oncology
12.6.1 Generic
12.6.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.6.2 Innovative
12.6.2.1 Innovative Market, 2015 – 2027 (USD Billion)
12.7 Cns & Neurology
12.7.1 Generic
12.7.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.7.2 Innovative
12.7.2.1 Innovative Market, 2015 – 2027 (USD Billion)
12.8 Orthopedics
12.8.1 Generic
12.8.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.8.2 Innovative
12.8.2.1 Innovative Market, 2015 – 2027 (USD Billion)
12.9 Endocrinology
12.9.1 Generic
12.9.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.9.2 Innovative
12.9.2.1 Innovative Market, 2015 – 2027 (USD Billion)
12.10 Pulmonology
12.10.1 Generic
12.10.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.10.2 Innovative
12.10.2.1 Innovative Market, 2015 – 2027 (USD Billion)
12.11 Gastroenterology
12.11.1 Generic
12.11.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.11.2 Innovative
12.11.2.1 Innovative Market, 2015 – 2027 (USD Billion)
12.12 Nephrology
12.12.1 Generic
12.12.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.12.2 Innovative
12.12.2.1 Innovative Market, 2015 – 2027 (USD Billion)
12.13 Ophthalmology
12.13.1 Generic
12.13.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.13.2 Innovative
12.13.2.1 Innovative Market, 2015 – 2027 (USD Billion)
12.14 Others
12.14.1 Generic
12.14.1.1 Generic Market, 2015 – 2027 (USD Billion)
12.14.2 Innovative
12.14.2.1 Innovative Market, 2015 – 2027 (USD Billion)
Chapter 13 API Market: Regional Estimates & Trend Analysis
13.1. Definitions & Scope
13.2. Application Market Share Analysis, 2019 & 2027
13.3. API Market, By Application, 2015 To 2027
13.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
13.5. North America
13.5.1 North America Market Estimates And Forecast, 2015 – 2027
13.5.2 U.S.
13.5.2.1 U.S. Market Estimates And Forecast, 2015 – 2027
13.5.3 Canada
13.5.3.1 Canada Market Estimates And Forecast, 2015 – 2027
13.6. Europe
13.6.1 Europe Market Estimates And Forecast, 2015 – 2027
13.6.2 Germany
13.6.2.1 Germany Market Estimates And Forecast, 2015 – 2027
13.6.3 U.K.
13.6.3.1 U.K. Market Estimates And Forecast, 2015 – 2027
13.6.4 Spain
13.6.4.1 Spain Market Estimates And Forecast, 2015 – 2027
13.6.5 France
13.6.5.1 France Market Estimates And Forecast, 2015 – 2027
13.6.6 Italy
13.6.6.1 Italy Market Estimates And Forecast, 2015 – 2027
13.7. Asia Pacific
13.7.1 Asia Pacific Market Estimates And Forecast, 2015 – 2027
13.7.2 Japan
13.7.2.1 Japan Market Estimates And Forecast, 2015 – 2027
13.7.3 China
13.7.3.1 China Market Estimates And Forecast, 2015 – 2027
13.7.4 India
13.7.4.1 India Market Estimates And Forecast, 2015 – 2027
13.7.5 South Korea
13.7.5.1 South Korea Market Estimates And Forecast, 2015 – 2027
13.7.6 Australia
13.7.6.1 Australia Market Estimates And Forecast, 2015 – 2027
13.8. Latin America
13.8.1 Latin America Market Estimates And Forecast, 2015 – 2027
13.8.2 Brazil
13.8.2.1 Brazil Market Estimates And Forecast, 2015 – 2027
13.8.3 Mexico
13.8.3.1 Mexico Market Estimates And Forecast, 2015 – 2027
13.8.4 Argentina
13.8.4.1 Argentina Market Estimates And Forecast, 2015 – 2027
13.9. Mea
13.9.1 Mea Market Estimates And Forecast, 2015 – 2027
13.9.2 South Africa
13.9.2.1 South Africa Market Estimates And Forecast, 2015 – 2027
13.9.3 Saudi Arabia
13.9.3.1 Saudi Arabia Market Estimates And Forecast, 2015 – 2027
13.9.4 UAE
13.9.4.1 UAE Market Estimates And Forecast, 2015 – 2027
13.10.Swot Analysis, By Factor (Political & Legal, Economic And Technological)
13.10.1. North America
13.10.2. Europe
13.10.3. Asia Pacific
13.10.4. Latin America
13.10.5. Middle East & Africa
Chapter 14 Competitive Landscape
14.1 Company Profiles
14.1.1 ABBVIE, INC.
14.1.1.1 Company overview
14.1.1.2 Financial performance
14.1.1.3 Product benchmarking
14.1.1.4 Strategic initiatives
14.1.2 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
14.1.2.1 Company overview
14.1.2.2 Financial performance
14.1.2.3 Product benchmarking
14.1.2.4 Strategic initiatives
14.1.3 BRISTOL-MYERS SQUIBB COMPANY
14.1.3.1 Company overview
14.1.3.2 Financial performance
14.1.3.3 Product benchmarking
14.1.3.4 Strategic initiatives
14.1.4 CIPLA INC.
14.1.4.1 Company overview
14.1.4.2 Financial performance
14.1.4.3 Product benchmarking
14.1.4.4 Strategic initiatives
14.1.5 MERCK & CO., INC.
14.1.5.1 Company overview
14.1.5.2 Financial performance
14.1.5.3 Product benchmarking
14.1.5.4 Strategic initiatives
14.1.6 ALBEMARLE CORPORATION
14.1.6.1 Company overview
14.1.6.2 Financial overview
14.1.6.3 Product benchmarking
14.1.6.4 Strategic initiatives
14.1.7 AUROBINDO PHARMA
14.1.7.1 Company overview
14.1.7.2 Financial overview
14.1.7.3 Product benchmarking
14.1.7.4 Strategic initiatives
14.1.8 MYLAN N.V.
14.1.8.1 Company overview
14.1.8.2 Financial overview
14.1.8.3 Product benchmarking
14.1.8.4 Strategic initiatives
14.1.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.
14.1.9.1 Company overview
14.1.9.2 Financial overview
14.1.9.3 Product benchmarking
14.1.9.4 Strategic initiatives
14.1.10 SUN PHARMACEUTICAL INDUSTRIES, LTD.
14.1.10.1 Company overview
14.1.10.2 Financial overview
14.1.10.3 Product benchmarking
14.1.10.4 Strategic initiatives
14.1.11 DR. REDDY’S LABORATORIES LTD.
14.1.11.1 Company overview
14.1.11.2 Financial overview
14.1.11.3 Product benchmarking
14.1.11.4 Strategic initiatives

List of Tables

Table 1 Key international regulations & their impact on the civil engineering industry
Table 2 Global Civil Engineering market estimates & forecast, by planning & design, 2016 - 2027 (USD Billion)
Table 3 Global Civil Engineering market estimates & forecast, by construction, 2016 - 2027 (USD Billion)
Table 4 Global Civil Engineering market estimates & forecast, by maintenance, 2016 - 2027 (USD Billion)
Table 5 Global Civil Engineering market estimates & forecast, by other services, 2016 - 2027 (USD Billion)
Table 6 Global Civil Engineering market estimates & forecast, by real estate, 2016 - 2027 (USD Billion)
Table 7 Global Civil Engineering market estimates & forecast, by infrastructure, 2016 - 2027 (USD Billion)
Table 8 Global Civil Engineering market estimates & forecast, by industrial applications, 2016 - 2027 (USD Billion)
Table 9 Global Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 10 Global Civil Engineering market estimates & forecast, by government customers, 2016 - 2027 (USD Billion)
Table 11 Global Civil Engineering market estimates & forecast, by private customer, 2016 - 2027 (USD Billion)
Table 12 Global Civil Engineering market estimates & forecast, by other customer, 2016 - 2027 (USD Billion)
Table 13 North America civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 14 North America civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 15 North America Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 16 North America Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 17 U.S. Civil Engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 18 U.S. Civil Engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 19 U.S. Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 20 U.S. Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 21 Canada Civil Engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 22 Canada Civil Engineering market revenue, by Service, 2016 - 2027 (USD Billion)
Table 23 Canada Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 24 Canada Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 25 Mexico Civil Engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 26 Mexico Civil Engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 27 Mexico Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 28 Mexico Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 29 Europe civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 30 Europe civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 31 Europe Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 32 Europe Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 33 Germany civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 34 Germany civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 35 Germany Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 36 Germany Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 37 U.K. civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 38 U.K. civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 39 U.K. Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 40 U.K. Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 41 France civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 42 France civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 43 France Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 44 France Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 45 Italy civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 46 Italy civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 47 Italy Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 48 Italy Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 49 Spain civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 50 Spain civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 51 Spain Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 52 Spain Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 53 Russia civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 54 Russia civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 55 Russia Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 56 Russia Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 57 Turkey civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 58 Turkey civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 59 Turkey Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 60 Turkey Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 61 Asia Pacific civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 62 Asia Pacific civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 63 Asia Pacific Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 64 Asia Pacific Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 65 China civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 66 China civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 67 China Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 68 China Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 69 India civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 70 India civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 71 India Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 72 India Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 73 Japan civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 74 Japan civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 75 Japan Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 76 Japan Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 77 Korea civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 78 Korea civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 79 Korea Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 80 Korea Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 81 Indonesia civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 82 Indonesia civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 83 Indonesia Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 84 Indonesia Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 85 Central & South America civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 86 Central & South America civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 87 Central & South America Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 88 Central & South America Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 89 Brazil civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 90 Brazil civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 91 Brazil Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 92 Brazil Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 93 Argentina civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 94 Argentina civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 95 Argentina Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 96 Argentina Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 97 Middle East & Africa civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 98 Middle East & Africa civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 99 Middle East & Africa Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 100 Middle East & Africa Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 101 Saudi Arabia civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 102 Saudi Arabia civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 103 Saudi Arabia Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 104 Saudi Arabia Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 105 UAE civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 106 UAE civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 107 UAE Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 108 UAE Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)
Table 109 Qatar civil engineering market estimates & forecast, 2016 - 2027 (USD Billion)
Table 110 Qatar civil engineering market revenue, by service, 2016 - 2027 (USD Billion)
Table 111 Qatar Civil Engineering market revenue, by application, 2016 - 2027 (USD Billion)
Table 112 Qatar Civil Engineering market revenue, by customer, 2016 - 2027 (USD Billion)



List of Figures

FIG. 1 Civil engineering market snapshot
FIG. 2 Civil engineering market revenue, 2019 (USD Billion)
FIG. 3 Civil engineering market segmentation
FIG. 4 Civil engineering market revenue, 2016 - 2027 (USD Billion)
FIG. 5 Value chain analysis
FIG. 6 Market dynamics
FIG. 7 Civil engineering market driver impact
FIG. 8 Construction spending in Asia Pacific (USD Billion) & CAGR, 2013 - 2018 (%)
FIG. 9 Civil engineering market restraint impact
FIG. 10 Key opportunities prioritized
FIG. 11 New Market Avenues
FIG. 12 PESTEL analysis
FIG. 13 Global civil engineering market revenue, by services, 2019 & 2027 (USD Billion)
FIG. 14 Civil engineering market revenue by application, 2019 & 2027 (USD Billion)
FIG. 15 Civil engineering market for construction snapshot, by region, 2019 & 2027
FIG. 16 Competitive environment
FIG. 17 Strategy Framework

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[薬品有効成分の世界市場:合成種類別(バイオテック、合成)、メーカー種類別(キャプティブ、マーチャント)、種類別、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆